Literature DB >> 23624786

Abrogation of ER stress-induced apoptosis of alveolar epithelial cells by angiotensin 1-7.

Bruce D Uhal1, Hang Nguyen, MyTrang Dang, Indiwari Gopallawa, Jing Jiang, Vinh Dang, Shinji Ono, Konosuke Morimoto.   

Abstract

Earlier work showed that apoptosis of alveolar epithelial cells (AECs) in response to endogenous or xenobiotic factors is regulated by autocrine generation of angiotensin (ANG) II and its counterregulatory peptide ANG1-7. Mutations in surfactant protein C (SP-C) induce endoplasmic reticulum (ER) stress and apoptosis in AECs and cause lung fibrosis. This study tested the hypothesis that ER stress-induced apoptosis of AECs might also be regulated by the autocrine ANGII/ANG1-7 system of AECs. ER stress was induced in A549 cells or primary cultures of human AECs with the proteasome inhibitor MG132 or the SP-C BRICHOS domain mutant G100S. ER stress activated the ANGII-generating enzyme cathepsin D and simultaneously decreased the ANGII-degrading enzyme ACE-2, which normally generates the antiapoptotic peptide ANG1-7. TAPI-2, an inhibitor of ADAM17/TACE, significantly reduced both the activation of cathepsin D and the loss of ACE-2. Apoptosis of AECs induced by ER stress was measured by assays of mitochondrial function, JNK activation, caspase activation, and nuclear fragmentation. Apoptosis induced by either MG132 or the SP-C BRICHOS mutant G100S was significantly inhibited by the ANG receptor blocker saralasin and was completely abrogated by ANG1-7. Inhibition by ANG1-7 was blocked by the specific mas antagonist A779. These data show that ER stress-induced apoptosis is mediated by the autocrine ANGII/ANG1-7 system in human AECs and demonstrate effective blockade of SP-C mutation-induced apoptosis by ANG1-7. They also suggest that therapeutic strategies aimed at administering ANG1-7 or stimulating ACE-2 may hold potential for the management of ER stress-induced fibrotic lung disorders.

Entities:  

Keywords:  ADAM17/TACE; BRICHOS domain mutations; idiopathic pulmonary fibrosis; substituted peptide receptor antagonists

Mesh:

Substances:

Year:  2013        PMID: 23624786      PMCID: PMC3726942          DOI: 10.1152/ajplung.00001.2013

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  27 in total

Review 1.  Type II pneumocyte proliferation in vitro: problems and future directions.

Authors:  B D Uhal; K M Flowers; D E Rannels
Journal:  Am J Physiol       Date:  1991-10

2.  Endoplasmic reticulum stress in alveolar epithelial cells is prominent in IPF: association with altered surfactant protein processing and herpesvirus infection.

Authors:  William E Lawson; Peter F Crossno; Vasiliy V Polosukhin; Juan Roldan; Dong-Sheng Cheng; Kirk B Lane; Thomas R Blackwell; Carol Xu; Cheryl Markin; Lorraine B Ware; Geraldine G Miller; James E Loyd; Timothy S Blackwell
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-04-04       Impact factor: 5.464

3.  Induction of apoptosis and pulmonary fibrosis in mice in response to ligation of Fas antigen.

Authors:  N Hagimoto; K Kuwano; H Miyazaki; R Kunitake; M Fujita; M Kawasaki; Y Kaneko; N Hara
Journal:  Am J Respir Cell Mol Biol       Date:  1997-09       Impact factor: 6.914

4.  Pulmonary fibrosis--a possible mechanism.

Authors:  W M Haschek; H Witschi
Journal:  Toxicol Appl Pharmacol       Date:  1979-12       Impact factor: 4.219

5.  A surfactant protein C precursor protein BRICHOS domain mutation causes endoplasmic reticulum stress, proteasome dysfunction, and caspase 3 activation.

Authors:  Surafel Mulugeta; Vu Nguyen; Scott J Russo; Madesh Muniswamy; Michael F Beers
Journal:  Am J Respir Cell Mol Biol       Date:  2005-03-18       Impact factor: 6.914

6.  Extravascular sources of lung angiotensin peptide synthesis in idiopathic pulmonary fibrosis.

Authors:  Xiaopeng Li; Maria Molina-Molina; Amal Abdul-Hafez; Jose Ramirez; Anna Serrano-Mollar; Antonio Xaubet; Bruce D Uhal
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-07-14       Impact factor: 5.464

7.  Bleomycin-induced apoptosis of alveolar epithelial cells requires angiotensin synthesis de novo.

Authors:  Xiaopeng Li; Huiying Zhang; Valerie Soledad-Conrad; Jiaju Zhuang; Bruce D Uhal
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-11-15       Impact factor: 5.464

8.  Proapoptotic Bid is required for pulmonary fibrosis.

Authors:  G R Scott Budinger; Gökhan M Mutlu; James Eisenbart; Alyson C Fuller; Amy A Bellmeyer; Christina M Baker; Mindy Wilson; Karen Ridge; Terrence A Barrett; Vivian Y Lee; Navdeep S Chandel
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-14       Impact factor: 11.205

9.  Essential role for cathepsin D in bleomycin-induced apoptosis of alveolar epithelial cells.

Authors:  Xiaopeng Li; Heather Rayford; Ruijie Shu; Jiaju Zhuang; Bruce D Uhal
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2004-02-20       Impact factor: 5.464

10.  Misfolded BRICHOS SP-C mutant proteins induce apoptosis via caspase-4- and cytochrome c-related mechanisms.

Authors:  Surafel Mulugeta; Jean Ann Maguire; Jennifer L Newitt; Scott J Russo; Adam Kotorashvili; Michael F Beers
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-06-22       Impact factor: 5.464

View more
  24 in total

1.  The unfolded protein response controls ER stress-induced apoptosis of lung epithelial cells through angiotensin generation.

Authors:  Hang Nguyen; Bruce D Uhal
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-09-16       Impact factor: 5.464

Review 2.  Emerging concepts in smooth muscle contributions to airway structure and function: implications for health and disease.

Authors:  Y S Prakash
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-10-14       Impact factor: 5.464

3.  Losartan activates sirtuin 1 in rat reduced-size orthotopic liver transplantation.

Authors:  Eirini Pantazi; Mohamed Bejaoui; Mohamed Amine Zaouali; Emma Folch-Puy; Anabela Pinto Rolo; Arnau Panisello; Carlos Marques Palmeira; Joan Roselló-Catafau
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

4.  Molecular and cellular mechanisms of the inhibitory effects of ACE-2/ANG1-7/Mas axis on lung injury.

Authors:  Indiwari Gopallawa; Bruce D Uhal
Journal:  Curr Top Pharmacol       Date:  2014-01-01

5.  Endoplasmic reticulum stress, a new wrestler, in the pathogenesis of idiopathic pulmonary fibrosis.

Authors:  Lei Zhang; Yi Wang; Nuruliarizki Shinta Pandupuspitasari; Guorao Wu; Xudong Xiang; Quan Gong; Weining Xiong; Cong-Yi Wang; Ping Yang; Boxu Ren
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

Review 6.  The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7).

Authors:  Robson Augusto Souza Santos; Walkyria Oliveira Sampaio; Andreia C Alzamora; Daisy Motta-Santos; Natalia Alenina; Michael Bader; Maria Jose Campagnole-Santos
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

Review 7.  Lost after translation: insights from pulmonary surfactant for understanding the role of alveolar epithelial dysfunction and cellular quality control in fibrotic lung disease.

Authors:  Surafel Mulugeta; Shin-Ichi Nureki; Michael F Beers
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-07-17       Impact factor: 5.464

8.  Angiotensin-(1-7)/mas inhibits apoptosis in alveolar epithelial cells through upregulation of MAP kinase phosphatase-2.

Authors:  Indiwari Gopallawa; Bruce D Uhal
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-12-04       Impact factor: 5.464

Review 9.  The Witschi Hypothesis revisited after 35 years: genetic proof from SP-C BRICHOS domain mutations.

Authors:  Bruce D Uhal; Hang Nguyen
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-10-18       Impact factor: 5.464

Review 10.  A hypothesis for pathobiology and treatment of COVID-19: The centrality of ACE1/ACE2 imbalance.

Authors:  Krishna Sriram; Paul A Insel
Journal:  Br J Pharmacol       Date:  2020-05-22       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.